Home
About
FAQ
History (36)
Bioengineered self-seeding heart valves.
Organoid-on-a-chip and body-on-a-chip systems for drug screening and disease modeling.
Characterizing Frailty Status in the Systolic Blood Pressure Intervention Trial.
Piperazinyl-glutamate-pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregation.
Common pathway signature in lung and liver fibrosis.
See All 36 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Common pathway signature in lung and liver fibrosis.
Makarev E, Izumchenko E, Aihara F, Wysocki PT, Zhu Q, Buzdin A, Sidransky D, Zhavoronkov A, Atala A. Common pathway signature in lung and liver fibrosis. . 2016 07 02; 15(13):1667-73.
View in:
PubMed
subject areas
Gene Expression Profiling
Humans
Liver Cirrhosis
Pulmonary Fibrosis
Signal Transduction
Software
authors with profiles
Anthony Atala MD